Search
01/01/2022
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
Rao S.V., Kirsch B., Bhatt D.L., Coppolecchia R., Eikelboom J., James S.K., Jones W.S., Keller L., Hermanides R.S., Campo G., Ferreiro J.L., Mundl H., Alexander J.H., Hengstenberg C., Steinwender C., Alber H., Steringer-Mascherbauer R., Schober A., Auer J., Roithinger F.X., Von Lewinski D., Moertl D., Huber K., Coussement P., Hoffer E., Beauloye C., Janssens L., Vranckx P., De Raedt H., Vanassche T., Vrolix M., Rokyta R., Parenica J., Pelouch R., Motovska Z., Alan D., Kettner J., Polasek R., Cermak O., Sedlon P., Hanis J., Novak M., Belohlavek J., Horacek T., Leggewie S., Wenzel P., Vom Dahl J., Sievers B., Pulz J., Schellong S., Clemmensen P., Muller-Hennessen M., Rassaf T., Falukozi J., Ruzsa Z., Tomcsanyi J., Csanadi Z., Herczeg B., Koszegi Z., Vorobcsuk A., Kiss R., Baranyai C., Dezsi C., Merkely B., Lupkovics G., Rossini R., Scherillo M., Sergio Saba P., Calo L., Nassiacos D., Quadri G., Sciahbasi A., Silvio Marenzi G.C., Reimers B., Perna G.P., Sacca S., Fattore L., Brunelli C., Picchi A., Kuramochi T., Kondo K., Aoyama T., Kudoh T., Yamamoto T., Takaya T., Mukai Y., Fukui K., Morioka N., Ando K., Yamamuro A., Morita Y., Koga Y., Watanabe T., Sakamoto T., Shibasaki T., Maebuchi D., Takahashi A., Yonetsu T., Kakuta T., Nishina H., Oemrawsingh R., Dorman R., Oude Ophius T., Prins P., Al Windy N.Y.Y., Zoet-Nugteren S.K., Hermanides R., Van Eck M., Scherptong R., Cornel J.H., Damman P., Bech G., Torquay R., Kietselaer B., Grzelakowski P., Krzysztof D., Budaj A., Miekus P., Przybylski A., Zarebinski M., Balsam P., Szachniewicz J., Gierlotka M., Tycinska A., Iniguez Romo A., Fernandez Ortiz A., Carrasquer Cucarella A., Sanmartin Fernandez M., Sionis A., Bueno Zamora H., Ferreiro Gutierrez J.L., Almenar L., Ferreira Gonzalez I., Pascual Figal D.A., Almendro Delia M., Jimenez Fernandez M., Skeppholm M., Zedigh C., Angeras O., Lauermann J., Erlinge D., Gustafsson R., Mooe T., Utreras A., James S., Grimfjard P., Pedrazzini G., Mach F., Fournier S., Haegeli L., Beer J.H., Leibundgut G., Kobza R., Kaiser C., Kunadian V., Al-Lamee R., Gorog D., Khan S., Trevelyan J., Toor I., Smith J., Purushottam B., Treasure C., Arena F., Vedere A., Henderson D., Gilani S., Jones A., Carrillo-Jimenez R., Gillespie E., Marhefka G., Wang D., Olson C., Bloom S., Iftikhar F., Brabham D., McGinty J., Thompson C., Talano J., Ginete W., Williams M., Masud A., Ariani M., Bitar F., Wang T., Samuelson B.. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction. CIRCULATION. 2022; 146(16)DOI:10.1161/CIRCULATIONAHA.122.061612. PMID:36030390. IF:37.800(Q1/1D).
01/01/2022
Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants
Corrochano M., Acosta-Isaac R., Plaza M., Muñoz R., Mojal S., Moret C., Souto J.C.. Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants. PLoS One. 2022; 17(12)DOI:10.1371/journal.pone.0278693. PMID:36490245. IF:3.700(Q2/4D).
01/01/2022
Comparación de dos programas de posprocesamiento de imágenes de cardiorresonancia magnética en un modelo porcino de infarto de miocardio
Radike M., Ben-Aicha S., Gutiérrez M., Hidalgo A., Badimón L., Vilahur G.. Comparación de dos programas de posprocesamiento de imágenes de cardiorresonancia magnética en un modelo porcino de infarto de miocardio. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 76(2)DOI:10.1016/j.recesp.2022.06.007. PMID:35809893. IF:5.900(Q1/3D).
01/01/2022
European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment
Lee G.A., Aktaa S., Baker E., Gale C.P., Yaseen I.F., Gulati G., Asteggiano R., Szmit S., Cohen-Solal A., Abdin A., Jurczak W., Garrido Lopez P., Sverdlov A.L., Tocchetti C.G., Barac A., Parrini I., Zamorano P., Iakobishvili Z., Pudil R., Badimon L., Kirby A.M., Blaes A.H., Farmakis D., Curigliano G., Stephens R., Lyon A.R., Lopez-Fernandez T.. European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment. European Heart Journal-Quality of Care and Clinical Outcomes. 2022; 9(1)DOI:10.1093/ehjqcco/qcac070. PMID:36316010. IF:5.200(Q2/3D).
01/01/2022
Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients
Pérez de Isla L., Alonso R., Argüeso R., Muñiz-Grijalvo O., Álvarez-Baños P., Badimón L., Watts G.F., Mata P.. Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients. Journal of Clinical Lipidology. 2022; 16(5)DOI:10.1016/j.jacl.2022.07.007. PMID:35906178. IF:4.400(Q2/3D).
01/01/2022
Percutaneous tricuspid valve repair after orthotopic heart transplantation
Maestro Benedicto A., Asmarats Serra L., Li C.H.P., Mirabet Pérez S.. Percutaneous tricuspid valve repair after orthotopic heart transplantation. Rec: Cardioclinics. 2022; 57(2)DOI:10.1016/j.rccl.2021.12.002. PMID:. IF:(Q/D).
01/01/2022
Systems Biology in Chronic Heart Failure—Identification of Potential miRNA Regulators
Vilella-Figuerola A., Gallinat A., Escate R., Mirabet S., Padró T., Badimon L.. Systems Biology in Chronic Heart Failure—Identification of Potential miRNA Regulators. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(23)DOI:10.3390/ijms232315226. PMID:36499552. IF:5.600(Q1/3D).
01/01/2022
Arachnoid membrane as a source of sphingosine-1-phosphate that regulates mouse middle cerebral artery tone
Jimenez-Altayo, F, Marzi, J, Galan, M, Dantas, AP, Ortega, M, Rojas, S, Egea, G, Schenke-Layland, K, Jimenez-Xarrie, E, Planas, AM. Arachnoid membrane as a source of sphingosine-1-phosphate that regulates mouse middle cerebral artery tone. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2022; 42(1)DOI:10.1177/0271678X211033362. PMID:34474613. IF:6.300(Q1/2D).